Caeli Nova

The Caeli Nova team aims to create oxygenation solutions that have applications outside the aviation industry.

History

2022: Attracting 7.7 million euros of investments

On January 20, 2022, it became known that the international development company of a comprehensive health control solution Ornament Health AG became the leading investor in the patented oxygen system for Caeli Nova aircraft. In total, 7.7 million euros were raised under this stage of financing. Caeli Nova has created and patented the Cordillera modified emergency oxygen system, the fundamental difference from the January 2022 systems is that it will reduce flight time, fuel consumption and reduce fuel emissions to the environment.

Health and safety issues are an absolute priority for us. That is why Ornament Health AG monitors developments in this area and contributes to the development of innovative technologies, said Snezhana Gurina, Executive Director of Ornament Health AG.

Cordillera technology not only improves the safety of air travel, but also is extremely profitable for air carriers from an economic point of view. It reduces flight time, fuel consumption, as well as the release of fuel into the environment, which is extremely important for the environment. Aircraft will reach their destination faster due to more direct routes, as well as safely moving even through highland regions, such as the Himalayas. It is also important that the Cordillera system is much lighter than existing ones.

As of January 2022, Cordillera is undergoing tests for compliance with international medical and regulatory requirements. Thanks to the investments received, it was possible to speed up the development process and attract international experts to it. Already in 2022, we can expect the signing of the first contracts and aircraft equipped with this system.